comparemela.com
Home
Live Updates
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results : comparemela.com
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
Q4 net sales from the eyecare and wound care segment grew 10% over the prior year with higher sales from the Avenova® physician dispensed and OTC channels, and from branded wound care...
Related Keywords
Canada ,
United States ,
American ,
Avenova Allograft ,
Justin Hall ,
Novabay Avenova ,
Pharmaceuticals Inc ,
Novabay Pharmaceuticals ,
Avenova Eye Health ,
Novabay Pharmaceuticals Inc ,
Facebook ,
Exchange Commission ,
Antimicrobial Lid ,
Flash Solution ,
Avenova Eye Health Support ,
Avenova Lubricating Eye Drops ,
Avenova Warm Eye Compress ,
Private Securities Litigation Reform Act ,
Stay Informed ,
Months Ended December ,
Ended December ,
Preferred Stock ,
Markets ,
comparemela.com © 2020. All Rights Reserved.